Source: Guideline 2020



Rating:

Share or cite this content

Citations should be made in the following way:
P. Nahid , S. Mase , G. Migliori et al.. Treatment of Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Guideline 2020

Member's Comments

No comment yet.

Related content which might interest you: Insights into the process used to develop the Official 2015 ATS/ERS/JRS/ALAT Clinical Practice Guidelines: Treatment of Idiopathic Pulmonary Fibrosis – An Update of the 2011 Clinical Practice Guideline Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis Year: 2015 Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline Source: Guideline 2018 Year: 2018 Tuberculosis: A Comprehensive Clinical Reference Source: Eur Respir J 2009; 34: 785 Year: 2009 An Official Research Policy Statement of the American Thoracic Society/European Respiratory Society: Standards for Quantitative Assessment of Lung Structure Source: Guideline 2010 Year: 2010 Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Research Needs on Respiratory Health in Migrant and Refugee Populations. An Official American Thoracic Society and European Respiratory Society Workshop Report Source: Guideline 2018 Year: 2018 An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management Source: Guideline 2011 Year: 2011 Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Book Review: Sleep Disordered Breathing in Children: A Comprehensive Clinical Guide to Evaluation and Treatment Source: Eur Respir Rev 2013; 22: 420 Year: 2013 The International Collaboration to Improve Respiratory Health in Children (INCIRCLE) ERS Clinical Research Collaboration Source: Eur Respir J, 52 (6) 1801867; 10.1183/13993003.01867-2018 Year: 2018 Impact on Adherence to the 2012 Evaluation and Management of Pediatric Community Acquired Pneumonia Philippine Academy of Pediatric Pulmonologist (PAPP) Update Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018 Evaluation of COPD Patient’s Relatives Assessment of Disease Awarness, Load of Care Giving and Loss of Workforce: Turkish Thoracic Society COPD Working Group. Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 Pan-Canadian Respiratory Standards Initiative for Electronic Health Records (PRESTINE): Validation of a Severe Asthma Algorithm Source: Virtual Congress 2021 – Digital health interventions in respiratory medicine Year: 2021 Use of the Asthma Control Questionnaire by the Asthma Clinical Research Network Source: Eur Respir J 2011; 38: 1242 Year: 2011 Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration Source: Eur Respir J, 53 (3) 1900217; 10.1183/13993003.00217-2019 Year: 2019 European Respiratory Society International Congress 2017: highlights from the Clinical Assembly Source: ERJ Open Res, 4 (1) 00134-2017; 10.1183/23120541.00134-2017 Year: 2018 Book review: Respiratory Care: Principles and Practice, Second Edition Source: Eur Respir Rev 2015; 24: 373 Year: 2015 Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration Source: Eur Respir J, 55 (5) 2001047; 10.1183/13993003.01047-2020 Year: 2020 Evaluation of the Integrated Tuberculosis Research Programme (PII TB) by SEPAR (Spanish Respiratory Society) Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019